$24.37-3.75%
2026-10-06 close · prelimStoke Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $37M. 2024 operating profit was −$101M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Stoke Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $37M. 2024 operating profit was −$101M.